FDAnews Drug Daily Bulletin

GlaxoSmithKline in Deal With MD Anderson on Cancer Drugs

Dec. 10, 2012
GlaxoSmithKline signed a collaboration agreement with the MD Anderson Cancer Center in Houston to develop new drugs that promote a patient’s immune system to attack cancer based on discoveries by Anderson researchers.